SCHEMBL24813170

SCHEMBL24813170

c1ccc(-c2cccc3c4ccccc4n(-c4ccc(-c5ccc(-c6ccc7c(c6)oc6ccccc67)cc5)cc4)c23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.38
MMP13 P45452 1/20 0.38
ATM Q13315 2/20 0.36
KDM4E B2RXH2 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PTGER4 P35408 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
AHR P35869 1/20 0.35
PLA2G2A P14555 2/20 0.35
PLA2G4A P47712 2/20 0.35
PRKDC P78527 2/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 1/20 0.35
DUSP3 P51452 1/20 0.34
ALOX5 P09917 1/20 0.34
HCRTR1 O43613 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24173829 0.93 PLA2G2A (0.40) ATMKDM4EL3MBTL1NPC1RAB9A
SCHEMBL25941012 0.92 KDM4E (0.35) MMP12MMP13ATMKDM4EL3MBTL1
SCHEMBL25940916 0.92 KDM4E (0.35) MMP12MMP13ATMKDM4EL3MBTL1
SCHEMBL27406832 0.92 PTGER4 (0.36) ATMKDM4EL3MBTL1PTGER4AHR
SCHEMBL16805675 0.92 MAPT (0.35) MMP12MMP13ATMKDM4EL3MBTL1
SCHEMBL20706809 0.91 KDM4E (0.42) MMP12MMP13ATMKDM4EL3MBTL1
SCHEMBL18963190 0.91 KDM4E (0.40) MMP12MMP13ATMKDM4EL3MBTL1
SCHEMBL21365490 0.91 PLA2G2A (0.40) ATMKDM4EL3MBTL1NPC1RAB9A
SCHEMBL25940864 0.90 KDM4E (0.38) MMP12MMP13ATMKDM4EL3MBTL1
SCHEMBL25941013 0.90 KDM4E (0.38) MMP12MMP13ATMKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 MMP12 2682/4885MMP13 2439/4885ATM 3436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.